The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA)

Clinical Nutrition

Volumn 22, Issue 1, 2003, Pages 17-22

  Nijveldt, R J ^a   Teerlink, T ^b   Siroen, M P C ^a   Van Lambalgen, A A ^a   Rauwerda, J A ^a   Van Leeuwen, P A M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Asymmetrical dimethylarginine; Kidney; Liver; Symmetrical dimethylarginine

Indexed keywords

DIMETHYLARGININASE; MICROSPHERE; N(G),N(G) DIMETHYLARGININE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ARTERIAL BLOOD; ARTICLE; BODY WEIGHT; CALCULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; KIDNEY; KIDNEY BLOOD FLOW; LIVER BLOOD FLOW; LIVER METABOLISM; MALE; NONHUMAN; RAT; RAT STRAIN; VENOUS BLOOD;

EID: 12244269690     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1054/clnu.2002.0612     Document Type: Article

References (41)

1. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992; 20 (Suppl 12): S60-S62
2. Matsuoka H, Itoh S, Kimoto M, Kohno K, Tamai O, Wada Y et al. Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension 1997; 29: 242-247.
3. Azuma H, Sato J, Hamasaki H, Sugimoto A, Isotani E, Obayashi S. Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells. Br J Pharmacol 1995; 115: 1001-1004
4. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575
5. + carrier hCAT-2B. Nitric Oxide 1997; 1: 65-73
6. Tojo A, Welch W J, Bremer V, Kimoto M, Kimura K, Omata M, Ogawa T et al. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney. Kidney Int 1997; 52: 1593-1601
7. Miyazaki H, Matsuoka H, Cooke J P, Usui M, Ueda S, Okuda S, Imaizumi T. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 1999; 99: 1141-1146
8. Kang E S, Tevlin M T, Wang Y B, Chiang T M, Cardenas R, Myers L K, Acchiardo S R. Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period. Am J Med Sci 1999; 317: 9-21
9. Cooke J P. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20: 2032-2037.
10. Carnegie P R, Fellows F C, Symington G R. Urinary excretion of methylarginine in human disease. Metabolism 1977; 26: 531-537
11. Yudkoff M, Nissim I, Pereira G, Segal S. Urinary excretion of dimethylarginines in premature infants. Biochem Med 1984; 32: 242-251
12. G-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody. Arch Biochem Biophys 1993; 300: 657-662
13. G-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J Biochem (Tokyo) 1995; 117: 237-238
14. Ito A, Tsao P S, Adimoolam S, Kimoto M, Ogawa T, Cooke J P. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999; 99: 3092-3095
15. Böger R H, Bode-Böger S M, Szuba A et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98: 1842-1847
16. G-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem 1989; 264: 10 205-10 209
17. Wu G, Morris S M J. Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336: 1-17
18. Hattori Y, Kasai K, Gross S S. Cationic amino acid transporter gene expression in cultured vascular smooth muscle cells and in rats. Am J Physiol 1999; 276: H2020-H2028
19. Idvall J, Aronsen K F, Nilsson L, Nosslin B. Evaluation of the microsphere method for determination of cardiac output and flow distribution in the rat. Eur Surg Res 1979; 11: 423-433
20. Prins H A, Houdijk A P J, Wiezer M J, Teerlink T, van Lambalgen A A, Thijs L G, van Leeuwen P A M. The effect of mild endotoxemia during low arginine plasma levels on organ blood flow in rats. Crit Care Med 2000; 28: 1991-1997
21. Houdijk A P J, van Leeuwen P A M, Boermeester M A et al. Glutamine-enriched enteral dietincreases splanchnic blood flow in the rat. Am J Physiol 1994; 267: G1035-G1040
22. Malik A B, Kaplan J E, Saba T M. Reference sample method for cardiac output and regional blood flow determinations in the rat. J Appl Physiol 1976; 40: 472-475
23. Teerlink T, Nijveldt R J, de Jong S, van Leeuwen P A M. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 2002; 303: 131-137
24. Kielstein J T, Böger R H, Bode-Böger S M, Schaffer J, Barbey M, Koch K M, Frolich J C. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 1999; 10: 594-600
25. Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Kidney Int 2001; 59 (Suppl) 78: S14-S18
26. Kielstein J T, Bode-Böger S M, Frolich J C, Haller H, Böger R H. Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerotic disease. Kidney Int 2001; 59 (Suppl) 78: S9-S13
27. Schmidt R J, Baylis C. Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 2000; 58: 1261-1266
28. Wahbi N, Dalton R N, Turner C, Denton M, Abbs I, Swaminathan R. Dimethylarginines in chronic renal failure. J Clin Pathol 2001; 54: 470-473
29. Fujiwara N, Osanai T, Kamada T, Katoh T, Takahashi K, Okumura K. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension : modulation of nitric oxide synthesis by salt intake. Circulation 2000; 101: 856-861
30. Holden D P, Fickling S A, Whitley G S, Nussey S S. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1998; 178: 551-556
31. Surdacki A, Nowicki M, Sandmann J et al. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 1999; 33: 652-658
32. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 1998; 62: 2425-2430
33. Bode-Böger S M, Böger R H, Kienke S, Junker W, Frolich J C. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 1996; 219: 598-603
34. Yu X J, Li Y J, Xiong Y. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. Life Sci 1994; 54: 753-758
35. G-dimethylarginine in rats. Arch Biochem Biophys 1987; 252: 526-537
36. Ogawa T, Kimoto M, Sasaoka K. Dimethylarginine: pyruvate aminotransferase in rats. Purification, properties, and identity with alanine: glyoxylate aminotransferase 2. J Biol Chem 1990; 265: 20 938-20 945
37. Kakimoto Y, Akazawa S. Isolation and identification of N-G,N-G- and N-G,N'-G-dimethyl-arginine, N-epsilon-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-delta-hydroxylysine from human urine. J Biol Chem 1970; 245: 5751-5758
38. Paik W K, Kim S. Protein methylation: chemical, enzymological, and biological significance. Adv Enzymol Relat Areas Mol Biol 1975; 42: 227-286
39. Najbauer J, Johnson B A, Young A L, Aswad D W. Peptides with sequences similar to glycine, arginine-rich motifs in proteins interacting with RNA are efficiently recognized by methyltransferase(s) modifying arginine in numerous proteins. J Biol Chem 1993; 268: 10 501-10 509
40. Nijveldt R J, Teerlink T, van der Hoven B, Siroen M P C, Kuik D J, Rauwerda J A, van Leeuwen P A M. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 2003 doi: 10.1054/clnu.2002.0613
41. Murray-Rust J, Leiper J, McAlister M et al. Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase. Nat Struct Biol 2001; 8: 679-683.